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Abstract  
Background: Skin temperature assessment is a promising modality for early detection of 
diabetic foot problems, but its diagnostic value has not been studied. Our aims were to 
investigate the diagnostic value of different cut-off skin temperature values for detecting 
diabetes-related foot complications such as ulceration, infection and Charcot foot, and to 
determine urgency of treatment in case of diagnosed infection or a red-hot swollen foot.  
Methods: The plantar foot surfaces of 54 diabetic patients visiting the outpatient foot clinic 
were imaged with an infrared camera. Nine patients had complications requiring immediate 
treatment; 25 patients had complications requiring non-immediate treatment; 20 patients had 
no complications requiring treatment. Average pixel temperature was calculated for six 
predefined spots and for the whole foot. We calculated the area under the receiver operating 
characteristic curve for different cut-off skin temperature values using clinical assessment as 
reference, and defined the sensitivity and specificity for the most optimal cut-off temperature 
value. Mean temperature difference between feet was analyzed using Kruskal-Wallis tests. 
Results: The most optimal cut-off skin temperature value for detection of diabetes-related foot 
complications was a 2.2°C difference between contralateral spots (sensitivity 76%; specificity 
40%). The most optimal cut-off skin temperature value for determining urgency of treatment 
was a 1.35°C difference between the mean temperature of the left and right foot (sensitivity 
89%; specificity 78%).  
Conclusion: Detection of diabetes-related foot complications based on local skin temperature 
assessment is hindered by low diagnostic values. Mean temperature difference between two 
feet may be an adequate marker for determining urgency of treatment.  
 
Introduction 
Foot complications, such as ulceration and infection, frequently occur in patients with 
diabetes and peripheral neuropathy and increase morbidity and mortality [1,2]. Early detection 
and timely treatment of diabetes-related foot complications and their pre-signs can prevent 
these devastating consequences [1]. However, early detection based on self-examination may 
be impeded by health impairments related to diabetes and other comorbidities or by social 
impairments. Frequent examination by health professionals is costly and may be too intrusive 
for patients. Automated telemedicine based on objective markers may overcome these 
disadvantages. Our ultimate objective is to develop an intelligent telemedicine system that can 
be deployed at the patient’s home for frequent examination of their feet to timely and 
automatically detect (pre-)signs of diabetes-related foot complications. Temperature 
assessment is a promising modality for such a system [3-5]. 
 
Inflammation precedes ulceration and infection, and this inflammation results in a 
temperature increase at the plantar foot surface [4]. As inflammation is only present in the 
affected foot, a difference in temperature can be observed between that location and the same 
location on the contralateral foot [4]. This can be accurately and reliably detected with an 
infrared thermometer, whereas the human hand is not an objective means for such assessment 
[3,6]. Using a 2.2ºC difference between two contralateral spots on the plantar foot surface as 
cut-off value to define presence of inflammation, a fourfold decrease in the risk of developing 
foot ulceration was found in a group of high-risk patients who performed skin temperature 
measurements twice a day compared with patients who performed structured daily foot care 
twice a day without skin temperature measurements [7-9]. However, this cut-off value of 
2.2ºC has been based on data from a small group of patients [10], and diagnostic values such 
as sensitivity and specificity of this cut-off value have not been published to date. As low 
sensitivity values may mean a failure to timely detect a developing complication and low 
specificity values may lead to over-diagnosis, insight in diagnostic values is needed to 
determine optimal application of skin temperature assessment in telemedicine systems. 
 
In the clinical studies mentioned above, an elegant and simple intervention was used that 
consisted of handheld infrared thermometry [7-9]. This constitutes, however, a measurement 
at low spatial resolution and temperature assessment at six selected spots only. Technological 
advancements in infrared imaging increase possibilities to quantify at high resolution the 
thermal pattern of the complete foot. Such advanced techniques may have the potential to 
differentiate between patients with complications that require immediate treatment at an 
emergency ward, such as with infection or a red-hot swollen foot indicative of a Charcot foot, 
and those that require non-immediate treatment at the outpatient clinic [5]. For example, if an 
increase in temperature is not the result of inflammation but of infection, delay in treatment of 
one day may have devastating consequences [11,12]. In a pilot study, we have recently 
proposed that a mean temperature difference >3°C between the ipsilateral and contralateral 
foot is indicative of diabetes-related foot complications that warrant immediate treatment [5]. 
This proposal warrants further investigation. 
 
The aims of the current study were: (i) to investigate the diagnostic values of different cut-off 
values for skin temperature for detecting diabetes-related foot complications such as 
ulceration, infection and Charcot foot; (ii) to investigate the diagnostic values of different cut-
off values for skin temperature to determine urgency of treatment in case of diagnosed 
infection or a red-hot swollen foot.  
  
Methods 
A convenience sample of 54 patients with diabetes mellitus who visited the multidisciplinary 
outpatient diabetic foot clinic of Hospital Group Twente (Almelo, the Netherlands) was 
included in this study. The Medical Ethical Committee Twente approved the study protocol 
and informed consent was obtained from each subject prior to the start of the study.  
 
Our ultimate objective is to develop an intelligent telemedicine system that can be deployed at 
the patient’s home, but the current system is not yet feasible for measurements in the home 
situation. To imitate the home situation as closely as possible, only patients whose last visit to 
the outpatient clinic was more than 14 days ago were included, and measurements were 
performed before treatment took place. Patients with critical ischemia (no palpable pedal 
pulses and a toe pressure <30mmHg) were excluded, as critical ischemia will lower 
temperature values [1,13]. Patients who had been hospitalized for diabetes-related foot 
complications within the last six months were also excluded, as treatment during 
hospitalization (such as minor amputations or prolonged treatment with antibiotics) may 
affect foot temperatures.  
 
For the current study, patients were measured at one occasion at the outpatient foot clinic. 
Patients were seated in supine position on a treatment bench. After shoes, socks, and (if 
applicable) dressings were removed, patients remained seated for a minimum of five minutes 
to allow equilibration of foot temperature [5]. Patients were asked to place their feet on 
support bars just inside the experimental setup (Figure 1), in such a way that their legs 
remained supported on the treatment bench. The experimental setup comprised two cameras 
(one for color images and one for thermal images), a light module, thermal reference 
elements, foot supports, a computer and a screen. The camera for color images was a Canon 
Eos-40D with EF-s 17-85mm lens, APS-C size (22.2x14.8mm) 10.5 megapixel single plate 
CMOS sensor, angle of view: horizontal (68º40’–15º25’), vertical (48–10º25’), and diagonal 
(78º30’–18º25’); field of view: 420x280mm, and USB 2.0 Hispeed computer interface. The 
camera for thermal images was a FLIR-SC305 with 16-bit resolution, 320x240 pixels, thermal 
sensitivity <0.05–30 °C, objective temperature range -20–120°C, focal length 18mm, angle of 
view: 25ºx19º, field of view: 420x315 mm, and computer interface: Ethernet IEEE 802.3. The 
light module consisted of 8 LZ1-10WWW05 LED, from LendEngin, Inc., size 4.4x4.4mm. 
All devices apart from the desktop computer and the screen were mounted in a wooden box of 
600x600x1900mm, with a light shielding extension in front. Ankle and legs were covered 
with a sterile cloth. The entrance of the light shielding extension of the setup was covered 
with a black cloth, to eliminate influence of the ambient. 
 
During the measurement, two images were acquired: one color image with all light sources on 
followed by a thermal image with all light sources off. Both cameras were driven and images 
were processed using custom-made MATLAB software (the Mathworks, MA). To 
discriminate the feet from the background, boundaries of the feet were automatically 
annotated in the color image and transferred to the thermal image [14]. Mean temperature and 
standard deviation across pixels encapsulated by these foot boundaries were calculated. 
Further, mean temperature across pixels was measured within circular masks of 10mm 
diameter that corresponded with the six plantar spots per foot that were previously defined in 
clinical studies [7-9]: hallux, first, third and fifth metatarsal head, metatarsocuneiform joint, 
and cuboid (Figure 2). When a spot was not available due to amputation, the contralateral spot 
was not measured either. Temperature differences between corresponding spots were 
calculated in SPSS for windows, version 17 (SPSS inc., Chicago, IL). 
 
After the measurement with the imaging system, a clinical foot assessment was performed by 
a certified wound care consultant trained in the diabetic foot, and in accordance with the 
diagnostic criteria described in international guidelines on the diabetic foot [1]. Diabetes-
related foot complications were defined as “infection, ulceration or destruction of deep tissues 
of the foot associated with neuropathy and/or peripheral arterial disease in the lower extremity 
of people with diabetes” [1]. Pre-signs of these complications, such as callus and blisters, 
were not included in this study. Infection was diagnosed using PEDIS criteria [1,15]. 
Diagnosis of neuropathy was based on a failed 10-g Semmes-Weinstein monofilament test 
[1]. Diagnosis of Charcot foot or osteomyelitis was confirmed by the findings of the 
radiologist on X-ray and magnetic resonance imaging (MRI). Treatment of complications 
after clinical assessment was recorded. All patients were followed for one month via regular 
outpatient or inpatient clinic visits, to monitor occurrence of new diabetes-related foot 
complications.  
 
Three groups of patients were defined based on the clinical foot assessment and subsequent 
treatment: 
Group 1 – “Complication: immediate treatment”: patients with a diabetes-related foot 
complication that required immediate treatment. Patients were assigned to group 1 if:  
- A patient was hospitalized for further treatment (irrespective of the reason for 
hospitalization); 
- A patient was prescribed with antibiotics; 
- A red-hot swollen foot indicative of a Charcot foot was diagnosed; 
- A patient was referred for advanced diagnostics (X-ray or MRI). 
If such complications would be diagnosed in the home situation, patients would be referred 
immediately to an emergency ward. 
Group 2 – “Complication: non-immediate treatment”: patients with a diabetes-related foot 
complication that required regular treatment at the outpatient foot clinic. This group consists 
of all patients with a diabetic foot complication, but without the need for immediate treatment 
as defined for group 1. These patients needed for example local wound care, sharp 
debridement or offloading. If such a complication would be diagnosed in the home situation, 
these patients would be referred to a multidisciplinary foot care within the next two days. 
Group 3 – “No complications”: patients without any diabetes-related foot complications that 
required treatment. 
Differences between these groups for age, gender and foot temperature were calculated with a 
Kruskal-Wallis test (non-parametric data).  
 
The most optimal cut-off value for skin temperature for detecting diabetes-related foot 
complications was determined based on the receiver operating characteristic (ROC) curve, 
and the area under the ROC curve as calculated using SPSS for Windows, version 17 (SPSS 
inc., Chicago, IL). Sensitivity, specificity, positive and negative predictive values that 
determine the most optimal cut-off value were determined. For detection of a diabetes-related 
foot complication, cut-off values for the skin temperature difference between two 
contralateral spots within one patient were investigated, based on a comparison between the 
combined groups 1 and 2 (i.e. presence of a diabetes-related foot complication) and group 3 
(i.e. no complication). Six contralateral spots were measured on both feet. The greatest 
temperature difference measured in any of the 6 pairs of spots was used for analysis, because 
one spot with a temperature difference exceeding a threshold is already indicative of a 
diabetes-related foot complication [7-10]. For determining urgency of treatment, cut-off 
values for the mean temperature difference measured between the whole left and right foot 
were investigated, based on a comparison between group 1 (i.e. immediate treatment) and the 
combined groups 2 and 3 (i.e. no need for immediate treatment). Data were analyzed using 
SPSS for Windows, version 17 (SPSS inc., Chicago, IL). Differences between groups were 
determined using Kruskal-Wallis tests for non-parametric data. Alpha was set at 0.05. 
 
Results 
Characteristics of the 54 included patients are shown in Table 1. All patients were diagnosed 
with peripheral neuropathy. Mean foot temperature ranged between 20.6 and 36.2°C across 
patients, and no significant differences were present between groups 1, 2 and 3 (Table 1). 
Mean temperature difference between the left and the right foot was 2.65°C in patients who 
needed immediate treatment (Group 1), which was significantly greater compared to the other 
two groups (p<0.001).   
 
The area under the ROC curve was 0.656 for detection of a diabetes-related foot complication 
(Figure 3A), when patients with a diabetes-related foot complication (groups 1 and 2) were 
compared with patients without a foot complication (group 3). The most optimal cut-off skin 
temperature value to detect a diabetes-related foot complication was 2.2°C. Using this value, 
sensitivity was 76%, specificity 40%, the positive predictive value 68% and the negative 
predictive value 50%.  
 
The area under the ROC curve was 0.812 for determining urgency of treatment (Figure 3B), 
when patients who needed immediate treatment (Group 1) were compared with patients who 
did not require immediate treatment (Groups 2 and 3). The most optimal cut-off skin 
temperature value to determine urgency of treatment was 1.35°C. Using this value, sensitivity 
was 89%, specificity 78%, the positive predictive value 44% and the negative predictive value 
97%.  
 Classification for determining a diabetes-related foot complication or urgency of treatment of 
patients within the three groups based on the most optimal cut-off value is shown in Table 2. 
 
None of the patients in Group 3 (no complications) developed any complications during the 
one-month follow-up. 
 
Discussion 
Preventing diabetes-related foot complications by early detection and timely treatment is 
important, considering the devastating consequences of these complications for morbidity and 
mortality [1,2]. Out of a variety of possible preventative measures, evidence for the 
monitoring of plantar foot temperatures twice a day giving a significant risk reduction for 
ulceration has been found in three randomized controlled trials [7-9]. However, temperature 
assessment has not yet found its way to daily clinical practice. Even though the efficacy has 
been proven in these randomized controlled trials, the effectiveness in daily practice can be 
impeded for various reasons. One of those reasons may be related to the diagnostic quality of 
temperature assessment. Low sensitivity values may mean a failure to timely detect diabetes-
related foot complications, whereas low specificity values may lead to over-referral and 
treatment. In this study, the diagnostic values of temperature assessment for detection of 
diabetes-related foot complications were investigated, as these values have not been reported 
earlier. 
 
The most optimal cut-off value when comparing two contralateral spots for detection of 
diabetes-related foot complications was found at 2.2°C, which is identical to the value used in 
the previous clinical studies that showed efficacy of foot temperature monitoring [7-9]. 
Despite being the most optimal cut-off value, sensitivity did not exceed 80% and specificity 
was as low as 40%. This suggests that the current algorithm for temperature assessment is not 
yet an adequate preventative method for the detection of diabetes-related foot complications 
in daily clinical practice. From the low specificity values it can be concluded that many 
patients that were not clinically diagnosed with diabetes-related foot complications had 
temperature differences exceeding 2.2°C between two contralateral spots (Table 2). As none 
of these patients developed complications in the month following the measurement, these 
temperature differences are not likely to be the result of inflammation preceding ulceration. 
Considering the temperature equilibrium period of five minutes before infrared imaging, the 
extent of ambulatory activity also does not seem a possible explanation for these differences. 
With both peripheral neuropathy and peripheral arterial disease being related to foot 
temperature [13,16,17], differences in degree of peripheral neuropathy and/or peripheral 
arterial disease between the left and right foot of a patient may be related to differences in 
measured temperature. However, it is not possible to draw any conclusions on this aspect 
from our current study. To allow further investigation of temperature differences between the 
left and right foot when no inflammation is present, temperature assessment should be 
combined with more advanced diagnostic methods for peripheral neuropathy or peripheral 
arterial disease in future studies, such as the vibration perception threshold or the 
microcirculation of the foot.  
 
Whereas the diagnostic values for detection of diabetes-related foot complications may not 
seem adequate, temperature assessment showed a more promising diagnostic value for 
determining the urgency of treatment. A mean temperature difference between the left and 
right foot exceeding 1.35°C was indicative of diabetes-related foot complications that require 
immediate treatment, with a sensitivity of 89% and specificity of 78%. A drawback of this 
algorithm is that complications requiring immediate treatment are not detected if they are 
present in both feet at the same time. This may be solved by combining temperature 
measurements with other imaging methods (e.g. photographic), or by monitoring patients over 
time. It should be noted, however, that the chance of having such complications in both feet at 
the same moment are small. 
 
Given the results of this study, it is important to search for methods that can optimize the 
diagnostic value for using skin temperature measurements for detecting diabetic foot 
complications. A first possible option is a more detailed analysis of the temperature patterns 
of the plantar foot surface. In the current study, we have analyzed mean temperatures in six 
selected regions and in the whole foot, and compared findings between left and right feet. We 
chose to investigate such simple parameters, as these are preferred in telemedicine systems. 
However, more detailed analyses at higher resolution and more complex algorithms are 
possible with the current advanced infrared imaging systems. These analyses or algorithms 
may consist of: (i) detecting temperature differences between left and right feet at any spot on 
the foot, and not only at six selected spots; (ii) analyzing the size of detected hotspots, by 
calculating the number of contralateral pixels that exceed the 2.2°C threshold. Within this 
aim, it can be hypothesized that larger hotspots are indicative of (more severe) diabetes-
related foot complications, whereas smaller hotspots may be related to no or less severe 
complications; (iii) detecting temperature differences within one foot (without the need of the 
contralateral foot); (iv) advanced statistical pattern recognition analysis, to determine patterns 
indicative of diabetes-related foot complications; or (v) monitoring patients over time, to 
investigate temporal changes in individual temperature patterns. 
 
A second option for optimizing diagnostic quality of skin temperature measurements for 
detecting diabetes-related foot complications is combining temperature assessment with other 
methods feasible for telemedicine. Photographic imaging is a method that has been studied in 
telemedicine systems, also in combination with temperature assessment, and has proven 
adequate in detecting diabetes-related foot complications such as ulceration [18,19]. However, 
the disadvantage of photographic imaging is the need for a clinical assessor since automated 
analysis of photographic images is not yet possible. Daily use of such a method places a 
burden on clinical practice. This disadvantage may be overcome by using more advanced 
imaging methods such as hyperspectral imaging or photometric stereo imaging, which have 
received already some attention in the last years [20-23]. These methods show promising 
early results, but are currently too expensive and more studies are awaited. Combining such 
methods in future studies with temperature assessment may result in more adequate diagnostic 
value for detecting diabetes-related foot complications. 
 
The current study was not without limitations. First, only nine patients were included in 
Group 1, those requiring immediate treatment. Differences in mean temperature compared to 
patients who did not need immediate treatment were significant, but that might be the result of 
a positive selection bias. Including more patients is needed to confirm these results in a larger 
group. Second, diagnostic values were calculated by comparing temperature measurements 
with live clinical assessment. It should be noted that the validity and reliability of clinically 
assessing diabetic foot complications can be quite low, and therefore this assessment should 
not be considered as gold standard [18,19]. Nevertheless, it is the method of choice for these 
kind of diagnostic studies. Blinding of the observers performing the clinical assessment for 
the results of the temperature measurements could not be completely guaranteed during, but 
the observers indicated that temperature measurements did not affect their assessment or their 
treatment. Third, the five-minute foot temperature equilibrium period was based on pilot 
measurements showing no changes after five minutes rest, as described in our previous study 
[5]. However, results from these pilot measurements have not been published, and the 
evidence for this equilibrium period can as such not be judged by others. Fourth, the 
experimental set-up could not be deployed at the patients’ home, so this was not a study on 
the use of a telemedicine system. All patients were measured at the outpatient clinic using the 
same protocol, but without controlling for pre-assessment activity or time of measurement. 
Some of these differences were controlled for by using a five-minute foot temperature 
equilibration period, but it cannot be ruled out that a factor such as physical activity in the 
hour before assessment may have affected the measurements.  
 
Conclusions 
Detection of diabetes-related foot complications based on skin temperature assessment (i.e. 
hotpots) using advanced infrared imaging is hindered by low diagnostic values, especially 
specificity, which increases chance for over-diagnosis. However, mean foot temperature 
difference between the left and right feet may be an adequate marker for determining urgency 
of treatment. Nevertheless, these results suggest that diagnostic values should be further 
optimized before temperature assessment can be widely implemented in telemedicine systems 
for use in daily clinical practice. Such optimization may potentially occur with more detailed 
analyses of skin temperature patterns or by combining skin temperature measurements with 
other diagnostic methods. 
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